Anti-MDA5 antibody as a monitoring marker of disease recurrence after lung transplantation in rapidly progressive interstitial lung disease patients.

被引：0

作者：

Kang, Eun-Suk ^{[1
,2
]}

Lee, Jong Kwon ^{[1
]}

Heo, Won Young ^{[1
]}

Jung, Mi Jeong ^{[2
]}

Lee, Junghee ^{[3
]}

Jeon, Yeong Jeong ^{[3
]}

Choi, Yong Soo ^{[3
]}

Jeon, Kyeongman ^{[4
]}

机构：

[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Lab Med & Genet, Seoul, South Korea

[2] Samsung Med Ctr, Res Inst Future Med, Seoul, South Korea

[3] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea

[4] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea

来源：

TRANSPLANTATION | 2024年 / 108卷 / 9S期

关键词：

D O I：

10.1097/01.tp.0001065004.59162.12

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

263.3

引用

页数：1

共 50 条

[21] Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome
Tanaka, Nao
Terao, Chikashi
Nakayama, Yoichi
Sasai, Tsuneo
Umezawa, Natsuka
Yagyu, Yuriko
Ito, Kanae
Koike, Ryuji
Nakashima, Ran
Hatta, Kazuhiro
Mizoguchi, Fumitaka
RHEUMATOLOGY, 2021, 60 (03) : E104 - E106
[22] A RARE CASE OF ANTI-MDA5 ANTIBODY-ASSOCIATED RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE WITHOUT CUTANEOUS MANIFESTATIONS
Tavakolian, Kameron
Douedi, Steven
Pannu, Viraaj
Miller, Brett
Odak, Mihir
Khan, Taimoor
Salam, Noor
CHEST, 2022, 162 (04) : 1183A - 1184A
[23] Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
Sakamoto, Noriho
Ishimoto, Hiroshi
Nakashima, Shota
Yura, Hirokazu
Miyamura, Takuto
Okuno, Daisuke
Hara, Atsuko
Kitazaki, Takeshi
Kakugawa, Tomoyuki
Ishimatsu, Yuji
Satoh, Minoru
Mukae, Hiroshi
INTERNAL MEDICINE, 2019, 58 (06) : 837 - 841
[24] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
Ho So
Victor Tak Lung Wong
Virginia Weng Nga Lao
Hin Ting Pang
Ronald Man Lung Yip
Clinical Rheumatology, 2018, 37 : 1983 - 1989
[25] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
So, Ho
Wong, Victor Tak Lung
Lao, Virginia Weng Nga
Pang, Hin Ting
Yip, Ronald Man Lung
CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1983 - 1989
[26] COVID-19 Leading to Accelerated Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Dermatomyositis
Dandu, S.
Farhat, F.
Akhlaq, H.
Udongwo, N.
Nannepaga, S.
Nadhim, A.
Abu Homoud, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[27] Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model
Wang, Lei
Lv, Chengyin
You, Hanxiao
Xu, Lingxiao
Yuan, Fenghong
Li, Ju
Wu, Min
Zhou, Shiliang
Da, Zhanyun
Qian, Jie
Wei, Hua
Yan, Wei
Zhou, Lei
Wang, Yan
Yin, Songlou
Zhou, Dongmei
Wu, Jian
Lu, Yan
Su, Dinglei
Liu, Zhichun
Liu, Lin
Ma, Longxin
Xu, Xiaoyan
Zang, Yinshan
Liu, Huijie
Ren, Tianli
Liu, Jin
Wang, Fang
Zhang, Miaojia
Tan, Wenfeng
FRONTIERS IN IMMUNOLOGY, 2024, 15
[28] FULMINANT ORGANIZING PNEUMONIA: A CASE OF ANTI-MDA5 AMYOPATHIC DERMATOMYOSITIS WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE
Pham, Andrew
Chesta, F. N. U.
Castaneda, Christian L.
CHEST, 2023, 164 (04) : 5732A - 5732A
[29] FDG PET/CT Findings of Rapidly Progressive Interstitial Lung Disease in a Patient With Anti-MDA5 Dermatomyositis
Zhang, Jun
Dong, Aisheng
CLINICAL NUCLEAR MEDICINE, 2025, 50 (01) : 80 - 82
[30] Successful Treatment of Rapidly Progressive Interstitial Lung Disease with Anti-MDA5 Antibodies with Immunosuppression Including Upadacitinib
Maiurano, L.
PEDIATRIC PULMONOLOGY, 2022, 57 : S132 - S132

← 1 2 3 4 5 →